Pavillon Jean-Coutu, Local 2254
Téléphone: 514-343-6111 poste 3011
Télécopieur: 514-343-2102
Courriel: yola.moride@umontreal.ca

Thèmes d’enseignement

• Pharmacoépidémiologie

• Gestion du Risque

• Pharmacovigilance

Thèmes de recherche

• Pharmacoépidémiologie

• Utilisation optimale

• Evaluation de Risque

• Gestion thérapeutique

Principaux projets de recherche en cours

• Evaluation de la non-persistance au traitement par antidépresseurs

• Programme de gestion thérapeutique pour optimiser le suivi de la dépression

• Antidépresseurs et suicide chez les enfants et adolescents

Publications représentatives

Moride Y, Hegele RA, Langer A, McPherson R, Miler DB, Rinfret S.  Clinical and Public Health Assessment of Benefit-risk of Statins in the Primary Prevention of Coronary Events: Resolved and Unresolved Issues.  Can J Cardiol, April 2008.

Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S.  Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication. Pharmacoepidemiol Drug Saf

Tournier M, Moride Y, Lesk M, Ducruet T, Rochon S.  The depletion of susceptibles effect in the assessment of burden-of-illness: The example of age-related macular degeneration in the community-dwelling elderly population of Quebec.  Can J Clin Pharmacol 2008;15:e22-e35.

Mikaeloff Y, Moride Y, Khoshnood B, Bréart G.  Infant and Toddler Disease Score was useful for risk of hopsitalization based on data from administrative claims.  J Clin Epidemiol 2007;60:680-685.

Gogovor A, Savoie M, Moride Y, Krelenbaum M, Montague T. Contemporary Disease Management In Québec.  Healthcare Quarterly 2007.

Tournier M, Moride Y, Ducruet T, Moshyk A, Rochon S.  The impact of visual impairment on the risk of depression and mortality in the community-dwelling elderly population of Quebec. Acta Scand Ophtalm 2007.

Earnshaw SR, Moride Y, Rochon S. Cost-effectiveness of pegaptanib (Macugen™) compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada. Clin Ther 2007;29(9):2096-106.

Martin K, Latry P, Moride Y, Begaud B. Where can we find French data for pharmacoepidemiology? A few thoughts. Rev Epidemiol Sante Publique 2007, Feb 23.